Nasdaq told Leo that the SP needs to be $4 when he called them. Everything else is approved. When a company applied to uplist, they can specify which tier. But it's up to Nasdaq to decide which standard the company qualifies under that tier. I think CTIX qualified for the Market Value of Listed Securities Standard under the Capital Market tier when Leo submitted the application. The closing price was over $2 for 90 days at that time.
My stance is the same as TOB. I’m confident that uplist will happen. But I care less about when. I care more about the pipeline progress. The more clinical trials are added, the happier I am. =)